Intellectual Property India Publishes Patent Application for 'Benzothiazole Compound And Use Thereof' Filed by Nanjing Reju Therapeutics, Inc.

MUMBAI, India, March 28 -- Intellectual Property India has published a patent application (202417105292 A) filed by Nanjing Reju Therapeutics, Inc., Jiangsu, China, on Dec. 31, 2024, for 'benzothiazole compound and use thereof.'

Inventor(s) include Ji, Yin; Wang, Xueping; and Zhai, Hui.

The application for the patent was published on March 28, under issue no. 13/2025.

According to the abstract released by the Intellectual Property India: "The present invention relates to a benzothiazole compound represented by formula (I), or a pharmaceutically acceptable salt, solvate, hydrate, polymorph, eutectic, tautomer, stereoisomer, or prodrug thereof. The present invention further relates to a use of the benzothiazole compound in the preparation ...